3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
75
Myelodysplastic Syndromes
20
Leukemia, Myelomonocytic, Chronic
10
Myeloproliferative Disorders
5
Hematologic Neoplasms
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Neoplasms
3
Hematologic Diseases
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, T-Cell
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
GATA2 Deficiency
2
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pathologic Complete Response
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Interventions
pembrolizumab
44
Carboplatin
35
Paclitaxel
27
Specimen Handling
18
Cyclophosphamide
16
Capecitabine
16
Magnetic Resonance Spectroscopy
14
sacituzumab govitecan
13
Gemcitabine
13
Taxes
12
Biopsy
12
130-nm albumin-bound paclitaxel
11
Albumin-Bound Paclitaxel
9
Doxorubicin
8
olaparib
7
Nivolumab
7
fludarabine
6
Cisplatin
6
eribulin
5
atezolizumab
5
Radiotherapy
5
Docetaxel
5
durvalumab
4
Fulvestrant
4
Epirubicin
4
Bevacizumab
4
veliparib
3
famitinib
3
abemaciclib
3
Vinorelbine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Azacitidine
×
90 days
×
Clear all
No trials found.